Publications by authors named "Chin-Wen Cheng"
J Chin Med Assoc
April 2024
Article Synopsis
- Chronic migraine (CM) significantly affects patients both clinically and socially, leading to a need for effective treatments.
- Gepants, a new class of medications targeting calcitonin gene-related peptide (CGRP) receptors, have shown safety and efficacy for acute migraine treatment, with atogepant being the first to receive FDA approval for CM prevention.
- While initial results for gepants in CM treatment are promising, more research is needed to enhance their effectiveness, particularly in combination with other migraine medications.
